Ass Prof Joakim Nordanstig (Sahlgrenska University Hospital, Sweden) discusses the 5-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) trial, which aims to evaluate the additional effects of modern invasive treatment in patients with intermittent claudication receiving modern best medical treatment.
Questions:
1. What is the background of this study?
2. What was the design of the study and what patients were included?
3. What are the study's endpoints?
4. Have these endpoints been met?
5. What conclusions can be made with these 5-year results?
6. What are the next steps?
7. What are the 'take-home' messages for clinicians?
Recorded remotely from Sweden, 2020.
Interviewer: Victoria Perroud
Recording editor: Natascha Wienand